发明公开
- 专利标题: REGENERATIVE CAR-T CELLS
-
申请号: US18082857申请日: 2022-12-16
-
公开(公告)号: US20230220041A1公开(公告)日: 2023-07-13
- 发明人: Thomas Ichim , Amit Patel , Timothy Warbington
- 申请人: CREATIVE MEDICAL TECHNOLOGIES, INC.
- 申请人地址: US AZ Phoenix
- 专利权人: CREATIVE MEDICAL TECHNOLOGIES, INC.
- 当前专利权人: CREATIVE MEDICAL TECHNOLOGIES, INC.
- 当前专利权人地址: US AZ Phoenix
- 主分类号: C07K14/725
- IPC分类号: C07K14/725 ; C07K14/54 ; C07K14/49 ; C07K14/515 ; C07K14/65 ; C07K14/475 ; C07K16/18 ; A61K35/17
摘要:
A method of creating antigen-specific, chimeric antigen receptor (CAR) T cells capable of secreting regenerative growth factors upon activation of said CAR. In one embodiment said regenerative CAR-T cells possess a CAR capable of selectively recognizing damaged tissue. In one embodiment said CAR recognizes damage-associated molecular patterns (DAMPs) such as ATP, HMGB-1, matricryptins, cold-inducible RNA-binding protein, histones and mitochondrial DNA. Upon activation of said CAR said regenerative CAR-T cell is induced to produce one or more regenerative growth factors. In some embodiments the invention provides a suicide gene in said regenerative CAR-T cells in order to remove said cells after their therapeutic purpose is completed.
信息查询